AVH — AVITA Medical Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for AVITA Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	6 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-14.4	-26.7	-35.4	-61.8	-48.6
Depreciation
Non-Cash Items	3.92	8.2	3.31	16.5	11.6
Unusual Items
Other Non-Cash Items
Changes in Working Capital	4.67	-1.2	-6.57	-4.68	3.44
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Cash from Operating Activities	-5.5	-19.1	-38	-48.9	-31.2
Capital Expenditures	-0.132	-0.452	-1.38	-9.17	-1.64
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Software Development Costs
Other Investing Cash Flow Items	-49.5	-18.9	2.99	46.5	14.1
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-49.7	-19.3	1.61	37.4	12.5
Financing Cash Flow Items	0	—	—	—	-1.06
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	0.007	0.9	40.4	3.51	14.9
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-55.2	-37.5	3.95	-8.07	-3.81